BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Burzynski Research Institute 

9432 Old Katy Road, Suite 200

Houston  Texas  77055  U.S.A.
Phone: 713-335-5697 Fax: 713-335-5699


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Services
Healthcare






 Company News
Burzynski Research Institute Signs Research Agreement with the University of Alabama at Birmingham, Division of Preventive Medicine, Biostatistics and Bioinformatics Shared Facility 9/29/2009 10:07:34 AM    More...
Burzynski Research Institute: Metastatic Colon Cancer: In a Randomized Phase II Clinical Study, Antineoplaston Therapy Doubled the 5-Year Survival Rate Following Curative Resection of Hepatic Metastases 5/27/2009 8:20:34 AM    More...
Burzynski Research Institute Presents Positive Results From Phase II Trials of ANP for Inoperable Brainstem Glioma at the Congress 5/11/2009 12:00:54 PM    More...
Burzynski Research Institute Announces Positive Results of Phase II ANP Clinical Trial 5/6/2009 8:41:24 AM    More...
Burzynski Research Institute Partners with Premier Research to Manage Phase III Clinical Study of Children with Newly-Diagnosed Diffuse Intrinsic Brainstem Glioma 1/26/2009 10:05:32 AM    More...
U.S. FDA Grants Orphan Drug Designation for Burzynski Research Institute’s Antineoplaston Treatment for Gliomas 12/2/2008 10:51:20 AM    More...
Burzynski Research Institute Presents Promising Phase II Data on Malignant Glioma 11/21/2008 8:45:48 AM    More...
Thought Leaders from Burzynski Research Institute Present Encouraging Data on Antineoplastons for Treatment of Malignant Gliomas 11/20/2008 9:42:41 AM    More...
Brain Tumor Survivors Visit Burzynski Research Institute, Manufacturer Of Life Saving Medication 10/19/2005 5:11:48 PM    More...
Burzynski Research Institute Receives Orphan Drug Designation For Antineoplastons A10 And AS2-1 For Treatment Of Brain Stem Glioma 10/19/2005 5:10:19 PM    More...